• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Novo Nordisk A/S

+ Add to Watchlist

NVO:US

45.9600 USD 0.2900 0.63%

As of 20:04:07 ET on 08/29/2014.

Company Profile for Novo Nordisk A/S (NVO)

Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.

Contact Information

Novo Nordisk A/S

Novo Alle
Bagsvaerd, 2880
Denmark
Phone: 45-44-44-88-88
Fax: 45-44-49-05-55

Key Executives for Novo Nordisk A/S (NVO)

Lars Rebien SorensenChief Executive OfficerKare SchultzPresident/COO
Jesper BrandgaardExec VP/CFOLars Fruergaard JorgensenExec VP/CIO
Mads Krogsgaard ThomsenExec VP/Chief Science OfficerLise KingoExec VP/Chief of Staffs
Jakob RiisExec VPKasper Roseeuw PoulsenVP/Head:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil